Chronic Lymphocytic Leukemia
Data on chronic lymphocytic leukemia published by researchers at Ohio State University
Published in Blood Weekly, May 7th, 2009
"We previously reported interim results of a phase 1 trial in patients with chronic lymphocytic leukemia (CLL) whereby flavopiridol was administered intravenously as a 30-minute bolus followed by 4-hour infusion. We now report full pharmacokinetic (PK) data, correlations of PK with clinical outcomes, and final response and progression-free survival (PFS)," scientists writing in the journal Blood report.
"Twenty-one (40%) of 52 patients with relapsed CLL achieved a partial response (PR) with a median PFS of 12 months. Responders included 17 (40%) of 43 fludarabine refractory patients, 7 (39%) of 18 patients with del(17p13), and 14 (74%) of 19 patients with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-05-07)
More Articles from Blood Weekly
- JAMA and Archives Journals
Remote or rural residence not associated with increased time to kidney transplantation - Robert Wood Johnson Foundation Health & Society Scholars
'Nature vs. nurture' study of deceased donor pairs in kidney transplantation - Acute Myeloid Leukemia
Study findings from K. Petrie et al provide new insights into acute myeloid leukemia - Acute Promyelocytic Leukemia
Studies from Shanghai Jiao Tong University have provided new data on acute promyelocytic leukemia - Apoptosis
Study results from Children's Hospital update understanding of apoptosis - Autoimmune Hemolytic Anemia
Reports outline autoimmune hemolytic anemia study findings from J.F. Dufour and colleagues - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
